{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:26:37Z","timestamp":1793831197050,"version":"4.6.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Significant tricuspid regurgitation (TR) can be found in patients with atrial fibrillation (AF). The results of previous studies are controversial about whether significant functional TR (FTR) in patients with AF leads to worse clinical outcomes. The aims of the study were to investigate the prevalence, predictors and prognosis of significant FTR in patients with AF with preserved left ventricular ejection fraction (LVEF).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The present study was a retrospective cohort study in patients with AF and preserved LVEF from May 2013 through January 2018. Significant FTR was defined as moderate to severe TR without structural abnormality of the tricuspid valve. Pulmonary hypertension (PH) was defined as pulmonary artery systolic pressure\u2009\u2265\u200950\u2009mmHg or mean pulmonary artery pressure\u2009\u2265\u200925\u2009mmHg determined by echocardiography. The adverse outcomes were defined as heart failure and death from any cause within 2\u2009years of follow up.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>A total of 300 patients with AF (mean age 68.8\u2009\u00b1\u200910.8\u2009years, 50% male) were included in the study. Paroxysmal and non-paroxysmal AF were reported in 34.7 and 65.3% of patients, respectively. Mean LVEF was 65.3\u2009\u00b1\u20096.3%. PH and significant FTR were observed in 31.3 and 21.7% of patients, respectively. Patients with significant FTR were significantly older, more female gender and non-paroxysmal AF, and had higher left atrial volume index and pulmonary artery pressure than those without. A total of 26 (8.7%) patients died and heart failure occurred in 39 (13.0%) patients. There was a statistically significant difference in the adverse outcomes between patients with significant and insignificant FTR (44.6% vs. 11.9%, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.010). Multivariable analysis showed that factors associated with significant FTR were female gender, presence of PH and left atrial volume index (OR\u2009=\u20092.61, 1.87, and 1.04, respectively). The predictors of the adverse outcomes in patients with AF were significant FTR, presence of PH and high CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score (OR\u2009=\u20095.23, 2.23 and 1.60, respectively).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Significant FTR was common in patients with AF, and independently associated with adverse outcomes. Thus, comprehensive echocardiographic assessment of FTR in patients with AF and preserved LVEF is fundamental in determining the optimal management.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01716-6","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T19:02:54Z","timestamp":1602010974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Significant functional tricuspid regurgitation portends poor outcomes in patients with atrial fibrillation and preserved left ventricular ejection fraction"],"prefix":"10.1186","volume":"20","author":[{"given":"Natthaporn","family":"Prapan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-8948","authenticated-orcid":false,"given":"Nithima","family":"Ratanasit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khemajira","family":"Karaketklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"1716_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","volume":"128","author":"R Zakeri","year":"2013","unstructured":"Zakeri R, Chamberlain AM, Roger VL, Redfield MM. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation. 2013;128:1085\u201393.","journal-title":"Circulation."},{"key":"1716_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129:837\u201347.","journal-title":"Circulation."},{"key":"1716_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0002-8703(96)90288-4","volume":"131","author":"PA Wolf","year":"1996","unstructured":"Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham study. Am Heart J. 1996;131:790\u20135.","journal-title":"Am Heart J"},{"key":"1716_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/01.CIR.82.3.792","volume":"82","author":"AJ Sanfilippo","year":"1990","unstructured":"Sanfilippo AJ, Abascal VM, Sheehan M, Oertel LB, Harrigan P, Hughes RA, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82:792\u20137.","journal-title":"Circulation."},{"key":"1716_CR5","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1253\/circj.66.913","volume":"66","author":"X Zhou","year":"2002","unstructured":"Zhou X, Otsuji Y, Yoshifuku S, Yuasa T, Zhang H, Takasaki K, et al. Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. Circ J. 2002;66:913\u20136.","journal-title":"Circ J"},{"key":"1716_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.echo.2019.08.016","volume":"33","author":"D Muraru","year":"2020","unstructured":"Muraru D, Guta AC, Ochoa-Jimenez RC, Bartos D, Aruta P, Mihaila S, et al. Functional regurgitation of Atrioventricular valves and atrial fibrillation: an elusive pathophysiological link deserving further attention. J Am Soc Echocardiogr. 2020;33:42\u201353.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ijcard.2017.05.031","volume":"243","author":"Y Takahashi","year":"2017","unstructured":"Takahashi Y, Izumi C, Miyake M, Imanaka M, Kuroda M, Nishimura S, et al. Actual management and prognosis of severe isolated tricuspid regurgitation associated with atrial fibrillation without structural heart disease. Int J Cardiol. 2017;243:251\u20137.","journal-title":"Int J Cardiol"},{"key":"1716_CR8","doi-asserted-by":"publisher","first-page":"e004897","DOI":"10.1161\/CIRCIMAGING.116.004897","volume":"10","author":"H Utsunomiya","year":"2017","unstructured":"Utsunomiya H, Itabashi Y, Mihara H, Berdejo J, Kobayashi S, Siegel RJ, et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2017;10:e004897.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1716_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1253\/circj.CJ-17-1334","volume":"82","author":"Y Abe","year":"2018","unstructured":"Abe Y, Akamatsu K, Ito K, Matsumura Y, Shimeno K, Naruko T, et al. Prevalence and prognostic significance of functional mitral and tricuspid regurgitation despite preserved left ventricular ejection fraction in atrial fibrillation patients. Circ J. 2018;82:1451\u20138.","journal-title":"Circ J"},{"issue":"3","key":"1716_CR10","first-page":"234","volume":"48","author":"B Ozlek","year":"2020","unstructured":"Ozlek B, Ozlek E, Tekinalp M, Kahraman S, Zencirkiran Agus H, Basaran O, et al. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: insights from the APOLLON registry. Turk Kardiyol Dern Ars. 2020;48(3):234\u201345.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"1716_CR11","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"1716_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1\u201339 e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0735-1097(00)00762-2","volume":"36","author":"CM Tribouilloy","year":"2000","unstructured":"Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB. Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Coll Cardiol. 2000;36:472\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","volume":"16","author":"WA Zoghbi","year":"2003","unstructured":"Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777\u2013802.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR16","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","volume":"30","author":"WA Zoghbi","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native Valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303\u201371.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR17","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685\u2013713.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1540-8175.2011.01565.x","volume":"29","author":"MQ Najib","year":"2012","unstructured":"Najib MQ, Vinales KL, Vittala SS, Challa S, Lee HR, Chaliki HP. Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation. Echocardiography. 2012;29:140\u20136.","journal-title":"Echocardiography."},{"key":"1716_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.echo.2006.09.013","volume":"20","author":"D Mutlak","year":"2007","unstructured":"Mutlak D, Lessick J, Reisner SA, Aronson D, Dabbah S, Agmon Y. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20:405\u20138.","journal-title":"J Am Soc Echocardiogr"},{"key":"1716_CR20","first-page":"315","volume":"48","author":"N Yamasaki","year":"2006","unstructured":"Yamasaki N, Kondo F, Kubo T, Okawa M, Matsumura Y, Kitaoka H, et al. Severe tricuspid regurgitation in the aged: atrial remodeling associated with long-standing atrial fibrillation. J Cardiol. 2006;48:315\u201323.","journal-title":"J Cardiol"},{"key":"1716_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jacc.2003.09.036","volume":"43","author":"J Nath","year":"2004","unstructured":"Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43:405\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/echo.12420","volume":"31","author":"K Ong","year":"2014","unstructured":"Ong K, Yu G, Jue J. Prevalence and spectrum of conditions associated with severe tricuspid regurgitation. Echocardiography. 2014;31:558\u201362.","journal-title":"Echocardiography."},{"key":"1716_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/CIRCIMAGING.111.967919","volume":"5","author":"Y Topilsky","year":"2012","unstructured":"Topilsky Y, Khanna A, Le Tourneau T, Park S, Michelena H, Suri R, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5:314\u201323.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1716_CR24","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/0735-1097(94)90302-6","volume":"24","author":"A Sagie","year":"1994","unstructured":"Sagie A, Schwammenthal E, Padial LR, Vazquez de Prada JA, Weyman AE, Levine RA. Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. J Am Coll Cardiol. 1994;24:446\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4250\/jcu.2015.23.3.136","volume":"23","author":"JH Park","year":"2015","unstructured":"Park JH, Shin SH, Lee MJ, Lee MD, Shim HI, Yoon J, et al. Clinical and echocardiographic factors affecting tricuspid regurgitation severity in the patients with lone atrial fibrillation. J Cardiovasc Ultrasound. 2015;23:136\u201342.","journal-title":"J Cardiovasc Ultrasound"},{"key":"1716_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jcmg.2014.07.018","volume":"7","author":"Y Topilsky","year":"2014","unstructured":"Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014;7:1185\u201394.","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:38:42Z","timestamp":1633502322000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01716-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Siriraj Institutional Review Board approved the study (Certificate of Approval no. Si 171\/2019) and agreed that the informed consent was not necessary due to the retrospective nature of the study. The information of all patients was anonymized and de-identified prior to analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no completing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}